These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11217683)

  • 41. [Sildenafil--adverse effects, complications and safety].
    Sperling H; Michel MC
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):4-6. PubMed ID: 12407928
    [No Abstract]   [Full Text] [Related]  

  • 42. [Usefulness of sildenafil in the treatment of erectile dysfunction in hemodialyzed men].
    Martín F; Reig A; Sarró F; Arenas MD; Ferrer R; González F; Gil MT; Egea J
    Nefrologia; 2001; 21(5):493-6. PubMed ID: 11795019
    [No Abstract]   [Full Text] [Related]  

  • 43. Economic aspects of medical erectile dysfunction therapies.
    Anastasiadis AG; Ghafar MA; Burchardt M; Shabsigh R
    Expert Opin Pharmacother; 2002 Mar; 3(3):257-63. PubMed ID: 11866676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Efficacy and safety of phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction].
    Shen ZJ; Yu YL
    Zhonghua Nan Ke Xue; 2005 Aug; 11(8):631-4. PubMed ID: 16138588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The cardiac patient and sexual activity in the era of sildenafil (Viagra). The Israel Heart Society Expert Consensus Document].
    Tzivoni D; Klein J; Hisdai D; Roth A
    Harefuah; 2000 Aug; 139(3-4):116-9. PubMed ID: 10979470
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical perspective on erectile dysfunction therapies.
    Mulhall JP
    Am J Manag Care; 2000 Aug; 6(12 Suppl):S641-3. PubMed ID: 11183417
    [No Abstract]   [Full Text] [Related]  

  • 47. [Measures for optimizing the efficacy of sildenafil on patients with erectile dysfunction].
    Deng CH; Guo HB
    Zhonghua Nan Ke Xue; 2005 May; 11(5):389-91. PubMed ID: 15934466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999.
    Boshier A; Wilton LV; Shakir SA
    BJU Int; 2004 Apr; 93(6):796-801. PubMed ID: 15049992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medical solutions to sexual problems continue to make sexological care and science essential to the successful treatment of male ED.
    Seftel AD
    J Sex Marital Ther; 2007; 33(5):467-8. PubMed ID: 17674229
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment with sildenafil and satisfaction with life in depressive patients with erectile dysfunction].
    Martínez-Sánchez E; Oyagüez Martín I; Carrasco Garrido P; Gil de Miguel A
    Actas Esp Psiquiatr; 2001; 29(5):293-8. PubMed ID: 11602085
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction].
    Chen Q; Wang N; Yao F; Lu X
    Zhonghua Nan Ke Xue; 2004 Apr; 10(4):302-4. PubMed ID: 15148932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physician-rated patient preference and patient- and partner-rated preference for tadalafil or sildenafil citrate: results from the Canadian 'Treatment of Erectile Dysfunction' observational study.
    Lee J; Pommerville P; Brock G; Gagnon R; Mehta P; Krisdaphongs M; Chan M; Chan J; Dickson R
    BJU Int; 2006 Sep; 98(3):623-9. PubMed ID: 16925764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Valuing Viagra: what is restoring potency worth?
    Kwok YS; Kim C
    Eff Clin Pract; 1999; 2(4):171-5. PubMed ID: 10539542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.
    Afif-Abdo J; Teloken C; Damião R; Koff W; Wroclawski E; Yamasaki R; Torres LO; Sabaneeff J; Faria G; Pompeo AC; Cortado P; Glina S
    BJU Int; 2008 Sep; 102(7):829-34. PubMed ID: 18537952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical, multicentric, and open study to evaluate the efficacy of and tolerance to sildenafil in patients with erectile dysfunction].
    Palha AP; Gomes FA; Martins AS; Pimenta A; Neves J; Gonçalves R; Ramos L; Abrantes P; Canhão A; Santos G; Carvalho LF; Soares J; Lima E; Rosa G
    Acta Med Port; 2002; 15(4):249-56. PubMed ID: 12525018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Paths to sexual satisfaction. What will stimulate the tired man?].
    Rautenstrauch J
    MMW Fortschr Med; 2001 Jan; 143(3):4-6. PubMed ID: 11215339
    [No Abstract]   [Full Text] [Related]  

  • 58. [The condition--not the drug--is decisive when it comes to subsidizing. Increased objectivity in the debate on subsidized "quality of life drugs" is required].
    Landtblom AM; Ertzgaard P
    Lakartidningen; 2000 May; 97(21):2612-4. PubMed ID: 10881521
    [No Abstract]   [Full Text] [Related]  

  • 59. Cost utility analysis of sildenafil compared with papaverine-phentolamine injections.
    Stolk EA; Busschbach JJ; Caffa M; Meuleman EJ; Rutten FF
    BMJ; 2000 Apr; 320(7243):1165-8. PubMed ID: 10784537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Managed care and sexual dysfunction. Based on a presentation by William Parham, MD.
    Am J Manag Care; 1999 Jan; 5(1 Suppl):S23-7; discussion S28-30. PubMed ID: 10345973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.